Dual antiplatelet therapy, drug-eluting stents and bioresorbable vascular scaffolds: Evolutionary perspectives

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.26099 ◽

2015 ◽

Vol 87 (5) ◽

pp. 909-919 ◽

Author(s):

Felipe N. Albuquerque ◽

Anna Bortnick ◽

Javaid Iqbal ◽

Yuki Ishibashi ◽

Gregg W. Stone ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Evolutionary Perspectives

Download Full-text

Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elective Noncardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia ◽

10.1053/j.jvca.2017.04.046 ◽

2017 ◽

Vol 31 (5) ◽

pp. 1857-1864 ◽

Author(s):

Michael Essandoh ◽

Adam A. Dalia ◽

Mazen Albaghdadi ◽

Barry George ◽

Nicoleta Stoicea ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Perioperative Management ◽

Dual Antiplatelet Therapy ◽

Noncardiac Surgery ◽

Metallic Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Download Full-text

A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Case Medical Research ◽

10.31525/ct1-nct03947229 ◽

2019 ◽

Author(s):

Keyword(s):

High Risk ◽

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Drug Eluting Stents ◽

Download Full-text

SHORT VERSUS LONG DURATION OF DUAL ANTIPLATELET THERAPY AFTER SECOND GENERATION DRUG-ELUTING STENTS IMPLANTATION IN DIABETICS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)01488-1 ◽

2021 ◽

Vol 77 (18) ◽

pp. 129

Author(s):

Manesh Kumar Gangwani ◽

Abeer Aziz ◽

Shazib Sagheer ◽

Priyanka Ahuja ◽

Wade Lee-Smith ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Second Generation ◽

Dual Antiplatelet Therapy ◽

Drug Eluting Stents ◽

Long Duration ◽

Download Full-text

Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2021.07.005 ◽

2021 ◽

Author(s):

Ovidio De Filippo ◽

Jeehoon Kang ◽

Francesco Bruno ◽

Jung-Kyu Han ◽

Andrea Saglietto ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Drug Eluting Stents ◽

Coronary Bifurcation ◽

Coronary Syndrome ◽

Coronary Bifurcation Lesions ◽

Drug Eluting ◽

Bifurcation Lesions

Download Full-text

TCTAP A-005 A Hybrid Strategy with Bioresorbable Vascular Scaffolds and Drug Eluting Stents for Treating Complex Coronary Lesions

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2017.03.030 ◽

2017 ◽

Vol 69 (16) ◽

pp. S3

Author(s):

Alfonso Ielasi ◽

Richard Jabbour ◽

Akihito Tanaka ◽

Massimo Leoncini ◽

Bernardo Cortese ◽

...

Keyword(s):

Drug Eluting Stents ◽

Hybrid Strategy ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Coronary Lesions

Download Full-text

Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study

International Journal of Cardiology ◽

10.1016/j.ijcard.2017.05.091 ◽

2017 ◽

Vol 246 ◽

pp. 20-25 ◽

Author(s):

Gennaro Giustino ◽

Björn Redfors ◽

Roxana Mehran ◽

Ajay J. Kirtane ◽

Usman Baber ◽

...

Keyword(s):

Diabetes Mellitus ◽

Sex Differences ◽

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Platelet Reactivity ◽

Coronary Thrombosis ◽

Drug Eluting Stents ◽

Download Full-text

Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials

Catheterization and Cardiovascular Interventions ◽

10.1002/ccd.26110 ◽

2015 ◽

Vol 87 (4) ◽

pp. 722-732 ◽

Author(s):

Khaled M. Ziada ◽

Ahmed Abdel-Latif ◽

Richard Charnigo ◽

David J. Moliterno

Keyword(s):

Systematic Review ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Antiplatelet Therapy ◽

Randomized Trials ◽

Dual Antiplatelet Therapy ◽

Meta Analysis ◽

Drug Eluting Stents ◽

Drug Eluting ◽

Download Full-text

A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds

Cleveland Clinic Journal of Medicine ◽

10.3949/ccjm.84.s4.05 ◽

2017 ◽

Vol 84 (12 suppl 4) ◽

pp. e20-e24 ◽

Author(s):

Ron Waksman

Keyword(s):

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds ◽

Download Full-text

A3825 Effectiveness and implications of six-month dual antiplatelet therapy following implanting drug-eluting stents

Journal of Hypertension ◽

10.1097/01.hjh.0000548609.51504.b1 ◽

2018 ◽

Vol 36 ◽

pp. e150 ◽

Author(s):

Shanghelin Yin ◽

Peng Xu ◽

Bian Wang ◽

Hong Yuan

Keyword(s):

Antiplatelet Therapy ◽

Dual Antiplatelet Therapy ◽

Drug Eluting Stents ◽

Download Full-text

Incidence of Stent Thrombosis With Bioresorbable Vascular Scaffolds in Comparison With Drug-Eluting Stents

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2015.10.101 ◽

2016 ◽

Vol 67 (7) ◽

pp. 891-892

Author(s):

Andrea Messori

Keyword(s):

Stent Thrombosis ◽

Drug Eluting Stents ◽

Vascular Scaffolds ◽

Drug Eluting ◽

Bioresorbable Vascular Scaffolds

Download Full-text